Bloomberg Environment | Waste Industry Asks EPA to Stay Enforcement During Pandemic

Elise Paeffgen comments on the U.S. Environmental Protection Agency’s ongoing need to focus on disinfectant regulations due to COVID-19.

Our Environment, Land Use & Natural Resources Group explains the implications of the Environmental Protection Agency’s decision to end its temporary policy to exercise enforcement discretion for noncompliance of routine monitoring and reporting during the COVID-19 pandemic.

The coming end to the COVID-19 public health emergency doesn’t mean the end of all FDA authorities exercised during the pandemic. Our FDA/Food, Drug & Device Team explores what will happen to the FDA’s emergency use authorizations and COVID-19 enforcement guidances, among other enforcement policies currently in effect.

Our FDA and Health Care Policy teams discuss how sponsors and manufacturers can prepare for legislative and regulatory changes that could come from the final Food and Drug Amendments (PDUFA VII) and what companies can do today to leverage their current capabilities for success.

CSI: Confidential Supervisory Information is not a show many banks would enjoy watching, but it’s one of three areas our Financial Services & Products Group notes banks should keep in mind if they become the subject of subpoenas, document requests, examinations, or investigations by government agencies.